Miyoshi Kazuya, Takahashi Hirotoshi, Uno Maya, Akai Masaaki, Moriyama Eiji, Nakagawa Tomio, Nomura Tsunehisa
Dept. of Breast and Endocrine Surgery, National Hospital Organization Fukuyama Medical Center.
Gan To Kagaku Ryoho. 2018 Dec;45(12):1767-1769.
Leptomeningeal metastasis(LM)is a rare complication in patients with breast cancer. We report 3 cases of LMs in patients with breast cancer who were treated with intrathecal methotrexate via an Ommaya reservoir. In 2 patients, a significant neurological improvement was observed, whereas in 1 patient there was no response. The overall survivals for the patients who experienced improvements were 22 and 9 months. Although we have no evidence for the efficacy of intrathecal chemotherapy for LMs in patients with breast cancer, its effects for some patients could be promising, after reservoir management and drug selection establishment.
软脑膜转移(LM)是乳腺癌患者中一种罕见的并发症。我们报告了3例乳腺癌患者发生软脑膜转移并通过Ommaya储液器接受鞘内注射甲氨蝶呤治疗的病例。2例患者神经功能有显著改善,而1例患者无反应。病情改善患者的总生存期分别为22个月和9个月。虽然我们没有证据表明鞘内化疗对乳腺癌患者的软脑膜转移有效,但在储液器管理和药物选择确定后,其对部分患者的效果可能是有前景的。